Renaissance Technologies's EXAS Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 601,376 shares of Exact Sciences Corporation (EXAS) worth $32.9 M, representing 0.04% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in EXAS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 678,485 shares. Largest reduction occurred in Q3 2017, reducing 792,211 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2015 | +12,160 | New Buy | 12,160 | $9.21 |
| Q1 2016 | +197,940 | Add 1627.80% | 210,100 | $6.74 |
| Q2 2016 | -210,100 | Sold Out | 210,100 | $0.00 |
| Q3 2016 | +365,300 | New Buy | 365,300 | $18.57 |
| Q4 2016 | -365,300 | Sold Out | 365,300 | $0.00 |
| Q1 2017 | +351,300 | New Buy | 351,300 | $23.62 |
| Q2 2017 | +457,300 | Add 130.17% | 808,600 | $35.37 |
| Q3 2017 | -792,211 | Reduce 97.97% | 16,389 | $47.10 |
| Q4 2017 | -16,389 | Sold Out | 16,389 | $0.00 |
| Q2 2018 | +86,300 | New Buy | 86,300 | $59.79 |
| Q3 2018 | +162,898 | Add 188.76% | 249,198 | $78.92 |
| Q4 2018 | -249,198 | Sold Out | 249,198 | $0.00 |
| Q1 2019 | +126,200 | New Buy | 126,200 | $86.62 |
| Q2 2019 | +265,360 | Add 210.27% | 391,560 | $118.04 |
| Q3 2019 | +128,240 | Add 32.75% | 519,800 | $90.37 |
| Q4 2019 | -519,800 | Sold Out | 519,800 | $0.00 |
| Q3 2020 | +142,330 | New Buy | 142,330 | $101.95 |
| Q4 2020 | +467,874 | Add 328.72% | 610,204 | $132.49 |
| Q1 2021 | -527,300 | Reduce 86.41% | 82,904 | $131.78 |
| Q2 2021 | -82,904 | Sold Out | 82,904 | $0.00 |
| Q3 2022 | +61,200 | New Buy | 61,200 | $32.48 |
| Q4 2022 | +42,100 | Add 68.79% | 103,300 | $0.05 |
| Q1 2023 | +220,800 | Add 213.75% | 324,100 | $0.07 |
| Q2 2023 | +285,200 | Add 88.00% | 609,300 | $0.09 |
| Q3 2023 | +678,485 | Add 111.35% | 1.29 M | $68.22 |
| Q4 2023 | -336,881 | Reduce 26.16% | 950,904 | $73.98 |
| Q1 2024 | +37,000 | Add 3.89% | 987,904 | $69.06 |
| Q2 2024 | -477,200 | Reduce 48.30% | 510,704 | $42.25 |
| Q3 2024 | -446,104 | Reduce 87.35% | 64,600 | $68.12 |
| Q4 2024 | -64,600 | Sold Out | 64,600 | $0.00 |
| Q1 2025 | +33,900 | New Buy | 33,900 | $43.29 |
| Q2 2025 | +494,904 | Add 1459.89% | 528,804 | $53.14 |
| Q3 2025 | +72,572 | Add 13.72% | 601,376 | $54.71 |
Renaissance Technologies's Exact Sciences Corporation Investment FAQs
Renaissance Technologies first purchased Exact Sciences Corporation (EXAS) in Q4 2015, acquiring 12,160 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Exact Sciences Corporation (EXAS) for 40 quarters since Q4 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to Exact Sciences Corporation (EXAS) was in Q3 2023, adding 1,287,785 shares worth $87.85 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 601,376 shares of Exact Sciences Corporation (EXAS), valued at approximately $32.9 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.04% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in Exact Sciences Corporation (EXAS) was 1,287,785 shares, as reported at the end of Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.